Calidi Biotherapeutics’ Directors Rush in Fresh Stock Options Amid Optimistic Pipeline Buzz.
Calidi Biotherapeutics sees insider confidence rise as key execs receive large stock option grants, signaling optimism for upcoming clinical milestones.
3 minutes to read